BETTERLIFE PHARMA INC. (BETRF) Financial Statements
BETTERLIFE PHARMA INC. (BETRF) files with the U.S. Securities and Exchange Commission under CIK 0001464165. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Net Income
- -3.62 million CAD
- Total Assets
- 224.96 thousand CAD
- Net Cash from Operations
- -2.02 million CAD
Fiscal year ended Jan 31, 2025. Latest periodic SEC filing: Jun 2, 2025. Source: SEC filings (EDGAR XBRL). Amounts in CAD.
Open the full financial statements for BETRF in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History